New shot aims to block deadly brain infection
NCT ID NCT07204457
Summary
This study is testing a new vaccine designed to protect against four types of meningococcal bacteria, which can cause serious brain and blood infections. It will involve about 1,123 healthy adults aged 19-55. Researchers will compare the new vaccine's safety and how well it triggers a protective immune response against an existing approved vaccine.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGOCOCCAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Catholic University of Eunpyeong St.Mary's Hospital
RECRUITINGSeoul, South Korea
Conditions
Explore the condition pages connected to this study.